BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6144292)

  • 21. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivation in mice as an index of adrenergic activity. II. The effects of atropines and ganglionic blocking agents on adrenergic salivation and temperature responses in mice.
    Koppanyi T; Maling HM
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):333-43. PubMed ID: 4403619
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic parasympathetic role in insulin resistance on an animal model of hypertension.
    Ribeiro RT; Afonso RA; Macedo MP
    Metabolism; 2007 Feb; 56(2):227-33. PubMed ID: 17224337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of the antihypertensive action of DL-alpha-monofluoromethyldopa: implications for the role of the sympathetic nervous system in maintenance of elevated blood pressure in spontaneously hypertensive rats.
    Fozard JR; Möhring J; Palfreyman MG; Koch-Weser J
    J Cardiovasc Pharmacol; 1981; 3(5):1038-49. PubMed ID: 6168849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial smooth muscle contractions in spontaneously hypertensive rats on a high-calcium diet.
    Pörsti I
    J Hypertens; 1992 Mar; 10(3):255-63. PubMed ID: 1315823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE EFFECTS OF NEOSTIGMINE UPON GANGLION RESPONSES AFTER ADMINISTRATION OF BLOCKING DRUGS.
    FENNER PA; HILTON JG
    Br J Pharmacol Chemother; 1963 Oct; 21(2):323-30. PubMed ID: 14081662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The enzyme inhibitor Trasylol in experimental shock caused by scalding in rats. Comparison with the ganglionic blocking agent Ecolid].
    VERAGUT UP
    Helv Chir Acta; 1962 Apr; 29():144-51. PubMed ID: 13925361
    [No Abstract]   [Full Text] [Related]  

  • 29. Antagonism by antimuscarinic and ganglion-blocking drugs of some of the behavioural effects of nicotine.
    Morrison CF; Goodyear JM; Sellers CM
    Psychopharmacologia; 1969; 15(5):341-50. PubMed ID: 4390931
    [No Abstract]   [Full Text] [Related]  

  • 30. Control of peripheral vascular resistance in perfused hindquarters of dogs: lack of effect of nicotinic and muscarinic ganglion block.
    Hancock JC; Hilton JG
    Eur J Pharmacol; 1975 Apr; 31(2):226-31. PubMed ID: 238854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ganglionic blocking compounds on in-vivo fluid secretion in the rat small intestine.
    Delbro DS; Lange S
    J Pharm Pharmacol; 1997 Nov; 49(11):1109-13. PubMed ID: 9401947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced ganglionic responses to substance P in spontaneously hypertensive rats.
    Hancock JC; Lindsay GW
    Peptides; 2000 Apr; 21(4):535-41. PubMed ID: 10822109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a ganglionic blocking agent on the accumulation of DOPA in peripheral organs.
    Andén NE; Grabowska-Andén M; Schwieler J
    Acta Physiol Scand; 1989 May; 136(1):131-2. PubMed ID: 2570503
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of a ganglionic blocking agent on the orthostatic response in the rat.
    Liu CT; Anderson KL; Lape HE; Rosenberg FJ
    Arch Int Pharmacodyn Ther; 1967 Jun; 167(2):465-72. PubMed ID: 6058779
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic central nicotinic blockade after a single administration of the bisquaternary ganglion-blocking drug chlorisondamine.
    Clarke PB
    Br J Pharmacol; 1984 Oct; 83(2):527-35. PubMed ID: 6148986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorisondamine, a non-competitive ganglionic blocker, antagonizes the cardiovascular effects of cocaine in conscious squirrel monkeys.
    Tella SR; Schindler CW; Goldberg SR
    Pharmacol Res; 1993 Apr; 27(3):233-9. PubMed ID: 8100996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ganglion blocking agents on nicotine extensor convulsions and lethality in mice.
    Aceto MD; Bentley HC; Dembinski JR
    Br J Pharmacol; 1969 Sep; 37(1):104-11. PubMed ID: 4390479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ganglionic blockade on noradrenaline release and cell injury in the acutely ischemic rat myocardium.
    Abrahamsson T; Almgren O; Holmgren S
    J Cardiovasc Pharmacol; 1982; 4(4):584-91. PubMed ID: 6181332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble Prorenin Receptor Increases Blood Pressure in High Fat-Fed Male Mice.
    Gatineau E; Gong MC; Yiannikouris F
    Hypertension; 2019 Oct; 74(4):1014-1020. PubMed ID: 31378099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies with the ganglionic blocking agent, chlorisondamine chloride in unanesthetized and anesthetized dogs.
    MAXWELL RA; PLUMMER AJ; OSBORNE MW
    Circ Res; 1956 May; 4(3):276-81. PubMed ID: 13317018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.